These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue. Elliott JM; Kent A J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656 [TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors. Brazell C; McClue SJ; Preston GC; King B; Stahl SM Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986 [TBL] [Abstract][Full Text] [Related]
4. Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity. Moretti-Rojas I; Ezrailson EG; Birnbaumer L; Entman ML; Garber AJ J Biol Chem; 1983 Oct; 258(20):12499-508. PubMed ID: 6313663 [TBL] [Abstract][Full Text] [Related]
5. Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding. Goodwin GM; Fraser S; Stump K; Fairburn CG; Elliott JM; Cowen PJ J Affect Disord; 1987; 12(3):267-74. PubMed ID: 3038985 [TBL] [Abstract][Full Text] [Related]
6. Evidence for an increase in functional platelet 5-HT2A receptors in depressed patients using the new ligand [125I]-DOI. Serres F; Azorin JM; Valli M; Jeanningros R Eur Psychiatry; 1999 Dec; 14(8):451-7. PubMed ID: 10683631 [TBL] [Abstract][Full Text] [Related]
7. [Review of findings on binding of tricyclic antidepressants]. Krulík R; Fisar Z Cesk Psychiatr; 1993 Apr; 89(2):71-8. PubMed ID: 8403025 [TBL] [Abstract][Full Text] [Related]
8. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Arora RC; Meltzer HY Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243 [TBL] [Abstract][Full Text] [Related]
9. Human platelet [125I]R-DOI binding sites. Characterization by in vitro autoradiography. Himeno A; Saavedra JM Neuropsychopharmacology; 1990 Feb; 3(1):25-32. PubMed ID: 2306333 [TBL] [Abstract][Full Text] [Related]
10. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353 [TBL] [Abstract][Full Text] [Related]
11. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Waeber C; Palacios JM Brain Res Mol Brain Res; 1994 Jul; 24(1-4):199-209. PubMed ID: 7968358 [TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751 [TBL] [Abstract][Full Text] [Related]